New Biose­cure draft fea­tures 2032 grand­fa­ther clause, five-year grace pe­ri­od for added com­pa­nies

Drug­mak­ers would have un­til 2032 to cut ties with WuXi AppTec and oth­er Chi­nese life sci­ences com­pa­nies, ac­cord­ing to an up­dat­ed draft of the close­ly …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.